Biodesix (BDSX) IPO Opens 25% Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts BDSX Hot Sheet
Join SI Premium – FREE
Today's IPO for Biodesix, Inc. (NASDAQ: BDSX) opened for trading at $13.59 after pricing 4,000,000 shares of its common stock at a public offering price of $18.00 per share.
In addition, Biodesix has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions.
Morgan Stanley and William Blair are acting as lead book-running managers for the offering. Canaccord Genuity is acting as lead manager and BTIG is acting as co-manager for the proposed offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees growing investor reluctance to fund AI infrastructure
- AI-fueled tech selloff in focus; Western Digital reports - what’s moving markets
- Premarket movers: Crown Castle jumps 7.5% on SpaceX talks; Autoliv slides
Create E-mail Alert Related Categories
IPOsRelated Entities
William Blair, Morgan Stanley, Canaccord Genuity, IPO, BTIGSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
